Abstract Details

Title How Well Does the ADAS-cog Measure the Spectrum of Alzheimer's Disease Severity? An Item Response Theory Analysis

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 171

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Steve Balsis	No disclosure on file
	No disclosure on file
Louise R. Rodino-Klapac (Sarepta Therapeutics)	Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Paul J. Massman, PhD (Baylor College of Medicine)	No disclosure on file
Rachelle S. Doody, MD, PhD	Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.

��ɫ����